Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • DESeq 2 shrinkage Wald test vs. LR test

    This is more a conceptual question to those in the know (particularly Mike Love, Simon Anders and Wolfgang Huber if you're reading).

    I'm doing a slightly quick a dirty analysis using DESeq2 to test for interactions between 3 biological conditions and expression changes over time (only between 2 time points, so one hope issues of sphericity/autocorrelation do not become an issue).

    The current implementation using the Wald test will, by default, apply a beta prior to moderate the effect sizes from the GLM. I understand the default implementation as the Wald test uses the effect size estimates to calculate the p-value that the effect is different from zero. The likelihood ratio test does not require an accurate effect size estimate as I understand it, therefore I assume that this is the reason there is no default implementation for the effect size estimate moderation, or is there a mathematical reason for this?

    Also, is there a way to extract the pre-moderated effect sizes in order to compare them to the moderated ones (regardless of which test is applied?).

    Thanks in advance.

  • #2
    hi Mike,

    Here's a post where I talk a bit about why we used the moderation of effect sizes only for the Wald test:

    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


    So it's default to have shrinkage with the Wald test, and no shrinkage with the LRT. Although both defaults can be overridden.

    Note that with interaction terms in the model, the shrinkage is only applied to the interaction terms (discussed in ?nbinomWaldTest and in the Methods of the preprint).

    There is a way to extract pre-moderated effect sizes in DESeq2 version 1.6, which will be released in October with Bioconductor v3.0. You simply:

    Code:
    results(dds, addMLE=TRUE)

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Advancing Precision Medicine for Rare Diseases in Children
      by seqadmin




      Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
      12-16-2024, 07:57 AM
    • seqadmin
      Recent Advances in Sequencing Technologies
      by seqadmin



      Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

      Long-Read Sequencing
      Long-read sequencing has seen remarkable advancements,...
      12-02-2024, 01:49 PM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 12-17-2024, 10:28 AM
    0 responses
    22 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 12-13-2024, 08:24 AM
    0 responses
    42 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 12-12-2024, 07:41 AM
    0 responses
    28 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 12-11-2024, 07:45 AM
    0 responses
    42 views
    0 likes
    Last Post seqadmin  
    Working...
    X